Literature DB >> 25892715

Production of Norovirus VLPs to size homogeneity.

Yuqi Huo1, Xin Wan2, Zejun Wang2, Shengli Meng2, Shuo Shen3.   

Abstract

Expression of full-length major capsid protein of Noroviruses (NoVs) in sf9 cells using recombinant baculovirus expression system leads to the formation of virus-like particles (VLPs) with two sizes. In our pursuit of VLPs with uniform sizes, we find that N terminal truncated capsid protein formed primary VLPs with an average size of 21 nm. This kind of VLPs showed similar binding patterns to those produced with full-length major capsid protein. HBGA-VLPs binding assay and saliva-VLPs blocking analysis, as well as stability test demonstrate that the smaller 21 nm VLPs might be an excellent candidate for NoVs vaccine.
Copyright © 2015 Elsevier B.V. All rights reserved.

Keywords:  Norovirus; Smaller viral particles; Truncated capsid protein; VLPs

Mesh:

Substances:

Year:  2015        PMID: 25892715     DOI: 10.1016/j.virusres.2015.04.009

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.

Authors:  Yuqi Huo; Xuhui Chen; Lijun Zheng; Jinling Huo; Shanfeng Zhang; Mingchen Wang; Yumei Wang
Journal:  Virus Genes       Date:  2016-05-27       Impact factor: 2.332

2.  Norovirus-like VP1 particles exhibit isolate dependent stability profiles.

Authors:  Ronja Pogan; Carola Schneider; Rudolph Reimer; Grant Hansman; Charlotte Uetrecht
Journal:  J Phys Condens Matter       Date:  2018-02-14       Impact factor: 2.333

3.  N-terminal VP1 Truncations Favor T = 1 Norovirus-Like Particles.

Authors:  Ronja Pogan; Victor U Weiss; Kevin Bond; Jasmin Dülfer; Christoph Krisp; Nicholas Lyktey; Jürgen Müller-Guhl; Samuele Zoratto; Günter Allmaier; Martin F Jarrold; Cesar Muñoz-Fontela; Hartmut Schlüter; Charlotte Uetrecht
Journal:  Vaccines (Basel)       Date:  2020-12-24

4.  The effect of proteolytic enzymes and pH on GII.4 norovirus, during both interactions and non-interaction with Histo-Blood Group Antigens.

Authors:  Manon Chassaing; Maëlle Robin; Julie Loutreul; Didier Majou; Gaël Belliot; Alexis de Rougemont; Nicolas Boudaud; Christophe Gantzer
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.